Gotu Kola And The Confusion With Brahmi

Two botanically unrelated plants are called brahmi in different parts of India, and the ambiguity travels with them onto American product labels. Sorting out which plant a source means is the first task with either one.

Two plants, one name

Bacopa monnieri is a small creeping marsh plant, and Centella asiatica is a broad-leafed creeper often sold as gotu kola. Regional usage assigns the name brahmi to one or the other.

They belong to different families and share no meaningful chemistry. The overlap is entirely linguistic, arising from separate traditions of use that converged on the same reputation for mental function.

Classical commentaries handle the two plants separately under names including mandukaparni for centella. The confusion is largely a product of later translation and modern commerce rather than the texts themselves.

How the mix-up reaches the shelf

A bottle labelled brahmi may contain either species, and only the Latin binomial resolves it. Some manufacturers print both names, some print one, and some print the Sanskrit alone.

Because the two plants are described as supporting similar things, a substitution is unlikely to be noticed by a buyer. Nothing about the powder announces which plant it came from.

The same ambiguity has affected the research record, where older papers occasionally identify a study material by common name only, leaving the species genuinely unclear.

What centella is described as doing

Traditional use places it with wound care, skin conditions and mental clarity, and it appears in both Ayurvedic and other Asian medical traditions in overlapping roles.

Modern interest has centred on a group of compounds associated with connective tissue and wound healing, studied topically as well as by mouth. The topical literature is the older of the two.

Cognitive research on the plant is thin and mostly small, and the reviews describe it as preliminary. That is a fair characterisation rather than a dismissal.

Why the distinction changes how evidence is read

Evidence attaches to a species, an extract and a preparation, not to a name. A trial of bacopa says nothing about a centella product, however the label is worded.

Pooling studies across the two plants would produce a meaningless average, which is why careful reviews state their species inclusion criteria explicitly at the start.

Where a source will not say which plant it studied, the honest reading is that the finding cannot be assigned to either. Ambiguous identification is a real limitation, not a technicality.

The practical consequence for a reader

Anyone comparing products or claims should look for the binomial and treat its absence as missing information. It is the single most informative thing on the label.

Both plants have reported adverse effects and possible interactions, and centella has been associated with liver injury in case reports. These belong in a conversation with a clinician.

The name brahmi identifies a reputation shared by two plants. It does not identify a medicine, and reading it as though it did is how the confusion persists.